Home » THIRD WAVE RESPONDS TO INNOGENETICS' LAWSUIT
THIRD WAVE RESPONDS TO INNOGENETICS' LAWSUIT
Third Wave Technologies Inc. (Nasdaq: TWTI - News) today responded to a lawsuit filed against it by Innogenetics N.V., Gent, Belgium, that alleges Third Wave is infringing one of Innogenetics' hepatitis C virus (HCV) patents. Innogenetics also filed a similar suit against Abbott Laboratories. Both suits were filed in U.S. District Court for the Western District of Wisconsin in Madison, Wis.
Yahoo News (http://biz.yahoo.com/prnews/050930/cgf005.html?.v=25)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May